Free Trial

National HealthCare (NHC) Financials

National HealthCare logo
$94.41 +0.41 (+0.44%)
As of 04:10 PM Eastern
Annual Income Statements for National HealthCare

Annual Income Statements for National HealthCare

This table shows National HealthCare's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Income / (Loss) Attributable to Common Shareholders
45 46 51 56 59 68 42 139 22 67 102
Consolidated Net Income / (Loss)
53 53 51 56 59 68 42 139 20 65 102
Net Income / (Loss) Continuing Operations
53 53 51 56 59 68 42 139 20 65 102
Total Pre-Tax Income
85 85 80 75 75 88 52 150 27 89 136
Total Operating Income
68 67 61 54 56 49 48 51 32 57 86
Total Gross Profit
361 374 376 392 398 404 407 408 400 429 496
Total Revenue
872 907 924 964 980 996 1,028 1,074 1,086 1,142 1,307
Operating Revenue
829 865 878 917 933 948 979 1,029 1,041 1,088 1,261
Other Revenue
42 42 46 47 48 49 49 45 45 54 46
Total Cost of Revenue
510 533 548 572 583 593 621 666 686 712 811
Operating Cost of Revenue
510 533 548 572 583 593 621 666 686 712 811
Total Operating Expenses
293 307 315 338 342 355 359 357 368 372 411
Selling, General & Admin Expense
217 227 231 250 254 268 275 267 289 288 321
Depreciation Expense
34 37 39 43 42 42 42 41 40 42 42
Other Operating Expenses / (Income)
42 43 45 45 46 44 42 42 38 42 47
Total Other Income / (Expense), net
17 18 20 20 19 39 4.27 99 -4.67 32 51
Interest & Investment Income
- - - - - 1.98 -22 81 -16 15 31
Other Income / (Expense), net
17 18 20 20 19 37 27 18 11 17 20
Income Tax Expense
32 32 30 19 16 20 10 11 7.25 23 34
Net Income / (Loss) Attributable to Noncontrolling Interest
- 0.00 0.00 -0.52 -0.27 -0.24 0.12 0.50 -2.47 -1.51 0.16
Basic Earnings per Share
$3.24 $3.34 $3.34 $3.70 $3.87 $4.47 $2.74 $9.03 $1.46 $4.36 $6.62
Weighted Average Basic Shares Outstanding
13.82M 13.89M 15.13M 15.19M 15.22M 15.27M 15.31M 15.35M 15.41M 15.31M 15.39M
Diluted Earnings per Share
$3.14 $3.20 $3.32 $3.69 $3.87 $4.44 $2.72 $8.99 $1.45 $4.34 $6.53
Weighted Average Diluted Shares Outstanding
14.22M 14.49M 15.21M 15.22M 15.24M 15.36M 15.37M 15.42M 15.45M 15.38M 15.60M
Weighted Average Basic & Diluted Shares Outstanding
13.80M 13.90M 15.10M 15.20M 15.26M 15.33M 15.37M 15.45M 15.36M 15.35M 15.45M
Cash Dividends to Common per Share
$1.34 $1.54 $1.75 $1.89 $1.98 $2.06 $2.08 $2.11 $2.26 $2.34 $2.42

Quarterly Income Statements for National HealthCare

This table shows National HealthCare's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Income / (Loss) Attributable to Common Shareholders
-2.43 6.35 12 16 10 28 26 27 43 6.08
Consolidated Net Income / (Loss)
-3.11 5.57 11 16 10 28 26 27 43 6.03
Net Income / (Loss) Continuing Operations
-3.11 5.57 11 16 10 28 26 27 43 6.03
Total Pre-Tax Income
-4.25 7.41 16 22 14 37 36 37 58 6.06
Total Operating Income
4.08 9.05 10 14 13 20 16 23 21 27
Total Gross Profit
98 97 102 107 106 114 114 121 127 135
Total Revenue
271 265 270 283 288 301 297 301 340 369
Operating Revenue
260 253 258 270 277 283 286 289 329 357
Other Revenue
11 12 12 13 11 18 11 11 12 12
Total Cost of Revenue
173 167 168 175 183 187 183 180 213 234
Operating Cost of Revenue
173 167 168 175 183 187 183 180 213 234
Total Operating Expenses
94 88 92 93 93 94 98 98 106 108
Selling, General & Admin Expense
73 71 71 73 72 71 77 78 83 83
Depreciation Expense
10 10 10 10 10 12 11 9.34 11 11
Other Operating Expenses / (Income)
10 6.59 10 9.99 10 11 10 11 13 14
Total Other Income / (Expense), net
-8.33 -1.64 5.71 8.35 1.00 17 20 14 37 -21
Interest & Investment Income
-11 -4.33 1.39 4.65 -3.09 12 14 9.12 33 -25
Other Income / (Expense), net
2.73 2.69 4.32 3.70 4.10 4.54 5.69 4.96 4.22 4.83
Income Tax Expense
-1.14 1.84 4.44 6.41 3.91 8.70 9.46 9.49 15 0.03
Net Income / (Loss) Attributable to Noncontrolling Interest
-0.68 -0.78 -0.44 -0.36 -0.27 -0.44 0.04 0.26 -0.09 -0.05
Basic Earnings per Share
($0.16) $0.42 $0.76 $1.06 $0.68 $1.86 $1.71 $1.74 $2.78 $0.39
Weighted Average Basic Shares Outstanding
15.45M 15.41M 15.34M 15.30M 15.30M 15.31M 15.35M 15.39M 15.41M 15.39M
Diluted Earnings per Share
($0.16) $0.41 $0.76 $1.06 $0.68 $1.84 $1.69 $1.73 $2.73 $0.38
Weighted Average Diluted Shares Outstanding
15.45M 15.45M 15.36M 15.32M 15.32M 15.38M 15.51M 15.56M 15.67M 15.60M
Weighted Average Basic & Diluted Shares Outstanding
15.34M 15.36M 15.32M 15.32M 15.32M 15.35M 15.40M 15.42M 15.44M 15.45M
Cash Dividends to Common per Share
$0.57 $0.57 $0.57 $0.59 $0.59 $0.59 $0.59 $0.61 $0.61 $0.61

Annual Cash Flow Statements for National HealthCare

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Net Change in Cash & Equivalents
-15 -31 -18 36 -13 6.09 97 -39 -45 51 -29
Net Cash From Operating Activities
82 83 91 94 98 100 203 62 8.74 111 107
Net Cash From Continuing Operating Activities
82 83 91 94 98 100 203 62 8.74 111 107
Net Income / (Loss) Continuing Operations
53 53 51 56 59 68 42 139 20 65 102
Consolidated Net Income / (Loss)
53 53 51 56 59 68 42 139 20 65 102
Depreciation Expense
34 37 39 43 42 42 42 41 40 42 42
Non-Cash Adjustments To Reconcile Net Income
13 1.90 1.28 2.33 -0.16 -19 72 -106 -0.44 -19 -32
Changes in Operating Assets and Liabilities, net
-19 -8.80 0.04 -6.20 -2.00 9.00 47 -11 -51 23 -5.03
Net Cash From Investing Activities
-67 -73 -81 -9.56 -34 -14 -64 -66 -5.98 -18 -237
Net Cash From Continuing Investing Activities
-67 -73 -81 -9.56 -34 -14 -64 -66 -5.98 -18 -237
Purchase of Property, Plant & Equipment
-53 -58 -63 -32 -30 -26 -22 -39 -30 -28 -28
Acquisitions
-1.98 -0.67 0.00 0.00 -0.53 -16 -6.65 -29 0.00 -2.70 -214
Purchase of Investments
-62 -61 -49 -31 -14 -13 -85 -109 -34 -34 -49
Sale of Property, Plant & Equipment
- - 0.00 0.00 4.30 0.00 6.75 - 4.18 0.00 2.10
Sale and/or Maturity of Investments
52 53 36 54 6.09 46 43 102 50 47 52
Other Investing Activities, net
-1.54 -5.68 -6.53 -0.45 0.00 -5.46 -0.43 8.84 3.88 -0.20 -0.01
Net Cash From Financing Activities
-30 -42 -27 -49 -77 -80 -42 -35 -48 -43 100
Net Cash From Continuing Financing Activities
-30 -42 -27 -49 -77 -80 -42 -35 -48 -43 100
Repayment of Debt
-2.44 -3.69 -3.28 -23 -45 -49 -50 - 0.00 0.00 -13
Repurchase of Common Equity
-7.00 0.00 -8.20 0.00 -0.87 -0.87 -0.05 -0.84 -9.90 -2.48 -14
Payment of Dividends
-27 -30 -26 -28 -30 -32 -29 -33 -34 -36 -36
Issuance of Debt
0.00 110 - - 0.00 0.00 40 - 0.00 0.00 150
Issuance of Common Equity
7.43 11 11 3.74 2.87 2.35 1.76 3.44 2.11 0.31 14
Other Financing Activities, net
-0.75 1.99 -0.64 -1.10 -4.45 -0.62 -4.16 -4.88 -5.50 -4.82 -1.17
Cash Interest Paid
2.24 2.97 4.53 5.18 4.90 3.12 1.43 0.85 0.49 0.29 3.42
Cash Income Taxes Paid
37 29 28 24 9.18 21 17 23 8.77 15 18

Quarterly Cash Flow Statements for National HealthCare

This table details how cash moves in and out of National HealthCare's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Net Change in Cash & Equivalents
-19 2.67 -0.19 28 17 5.71 -4.84 44 -51 -18
Net Cash From Operating Activities
-1.98 12 14 39 32 26 9.65 51 34 13
Net Cash From Continuing Operating Activities
-1.98 12 14 39 32 26 9.65 51 34 13
Net Income / (Loss) Continuing Operations
-3.11 5.57 11 16 10 28 26 27 43 6.03
Consolidated Net Income / (Loss)
-3.11 5.57 11 16 10 28 26 27 43 6.03
Depreciation Expense
10 10 10 10 10 12 11 9.34 11 11
Non-Cash Adjustments To Reconcile Net Income
20 -8.77 -2.06 -4.89 3.28 -15 -5.70 -17 -31 22
Changes in Operating Assets and Liabilities, net
-29 4.65 -5.42 18 8.77 1.11 -21 32 12 -27
Net Cash From Investing Activities
-0.65 2.83 -1.43 -0.82 -5.14 -10 -2.42 1.43 -224 -12
Net Cash From Continuing Investing Activities
-0.65 2.83 -1.43 -0.82 -5.14 -10 -2.42 1.43 -224 -12
Purchase of Property, Plant & Equipment
-7.53 -5.64 -6.64 -6.15 -6.51 -8.60 -5.96 -7.83 -5.66 -8.16
Purchase of Investments
-3.82 -5.08 -10 -4.13 -7.36 -12 -10 -14 -9.35 -16
Sale and/or Maturity of Investments
7.30 12 15 13 8.53 11 12 23 5.11 12
Other Investing Activities, net
3.40 -2.48 0.00 -0.41 0.21 -0.00 2.12 -0.23 0.14 -2.03
Net Cash From Financing Activities
-17 -12 -13 -10 -9.82 -9.83 -12 -7.61 139 -19
Net Cash From Continuing Financing Activities
-17 -12 -13 -10 -9.82 -9.83 -12 -7.61 139 -19
Repayment of Debt
- 3.50 - - - - - - - -10
Payment of Dividends
-8.83 -8.77 -8.75 -8.73 -9.04 -9.04 -9.05 -9.09 -8.02 -9.69
Issuance of Common Equity
0.16 0.83 0.00 0.01 0.25 0.05 8.41 2.83 2.23 0.80

Annual Balance Sheets for National HealthCare

This table presents National HealthCare's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Total Assets
1,074 1,045 1,087 1,097 1,081 1,287 1,362 1,403 1,275 1,311 1,524
Total Current Assets
323 279 291 329 322 341 457 427 354 406 424
Cash & Equivalents
70 38 26 59 43 50 147 108 59 107 76
Restricted Cash
27 27 26 6.40 9.97 30 31 10 54 57 20
Short-Term Investments
133 116 138 160 159 152 176 196 124 117 175
Note & Lease Receivable
0.44 0.46 3.26 1.45 1.29 1.70 0.93 0.45 0.30 0.50 0.51
Accounts Receivable
79 84 83 87 97 93 90 96 100 109 135
Inventories, net
7.13 7.57 7.51 7.15 7.47 7.44 8.78 8.58 7.09 7.39 9.04
Prepaid Expenses
2.26 2.17 2.65 2.86 3.86 6.64 2.98 7.36 10 8.86 9.06
Plant, Property, & Equipment, net
515 536 560 549 535 535 520 521 507 493 684
Plant, Property & Equipment, gross
822 875 933 959 979 1,017 1,030 1,064 1,081 1,102 1,282
Accumulated Depreciation
307 339 374 409 444 482 510 543 575 608 597
Total Noncurrent Assets
237 230 237 218 224 410 385 456 415 411 416
Long-Term Investments
176 189 198 182 186 166 166 118 105 126 136
Goodwill
18 18 18 18 21 21 21 168 168 168 170
Intangible Assets
- - - - - - 0.00 7.04 7.04 7.04 20
Other Noncurrent Operating Assets
8.79 8.45 5.24 4.87 5.60 208 184 161 133 109 88
Other Noncurrent Nonoperating Assets
3.63 2.31 2.13 1.91 1.71 1.73 1.74 1.73 1.08 1.17 1.23
Total Liabilities & Shareholders' Equity
1,074 1,045 1,087 1,097 1,081 1,287 1,362 1,403 1,275 1,311 1,524
Total Liabilities
340 414 418 393 346 508 564 495 398 400 541
Total Current Liabilities
184 151 151 155 158 195 281 263 198 214 235
Short-Term Debt
3.09 3.28 3.48 3.70 3.92 14 4.42 - 4.99 0.86 7.50
Accounts Payable
39 37 36 33 36 34 38 40 34 38 41
Accrued Expenses
60 65 66 67 68 70 86 107 73 84 93
Dividends Payable
7.00 6.00 6.82 7.30 7.62 7.97 7.99 8.49 8.75 9.05 9.42
Other Current Liabilities
39 39 39 44 43 69 94 108 78 83 84
Total Noncurrent Liabilities
156 264 267 238 189 313 283 232 200 186 306
Long-Term Debt
10 120 120 100 55 - - - - 0.00 130
Asset Retirement Reserve & Litigation Obligation
79 71 65 66 67 66 69 67 71 73 73
Noncurrent Deferred & Payable Income Tax Liabilities
0.00 9.10 22 18 19 24 14 6.85 11 17 36
Other Noncurrent Operating Liabilities
30 30 26 25 23 207 189 158 117 96 69
Total Equity & Noncontrolling Interests
734 631 670 703 734 779 798 908 878 910 983
Total Preferred & Common Equity
734 631 670 703 733 779 795 903 874 909 980
Total Common Equity
564 631 670 703 733 779 795 903 874 909 980
Common Stock
155 210 212 216 220 223 227 232 227 228 233
Retained Earnings
344 368 392 419 516 553 563 669 657 688 752
Accumulated Other Comprehensive Income / (Loss)
65 53 66 68 -2.75 2.56 5.06 1.61 -9.53 -6.60 -4.72
Noncontrolling Interest
- - 0.00 0.69 1.18 0.48 3.08 5.46 3.24 1.73 3.00

Quarterly Balance Sheets for National HealthCare

This table presents National HealthCare's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Total Assets
1,296 1,265 1,281 1,282 1,320 1,340 1,563
Total Current Assets
345 338 369 383 418 448 446
Cash & Equivalents
45 46 78 100 94 136 85
Restricted Cash
51 31 56 55 60 52 54
Short-Term Investments
132 142 115 110 124 134 165
Note & Lease Receivable
- - - - 0.49 0.71 0.58
Accounts Receivable
99 103 101 103 126 109 129
Inventories, net
7.30 6.95 7.00 7.37 6.76 6.63 7.84
Prepaid Expenses
10 8.21 11 7.56 6.75 8.79 4.89
Plant, Property, & Equipment, net
511 503 502 498 489 487 686
Plant, Property & Equipment, gross
1,076 1,088 1,097 1,102 1,066 1,073 1,283
Accumulated Depreciation
565 585 595 604 577 586 597
Total Noncurrent Assets
440 424 410 401 413 405 431
Long-Term Investments
121 121 113 110 136 137 144
Goodwill
168 168 168 168 168 168 170
Intangible Assets
7.04 7.04 7.04 7.04 7.04 7.04 20
Other Noncurrent Operating Assets
140 127 120 114 101 91 96
Other Noncurrent Nonoperating Assets
1.85 1.05 1.08 1.08 1.14 1.21 1.24
Total Liabilities & Shareholders' Equity
1,296 1,265 1,281 1,282 1,320 1,340 1,563
Total Liabilities
414 385 394 395 393 392 576
Total Current Liabilities
210 183 198 205 206 217 248
Short-Term Debt
4.91 - 3.39 2.13 0.00 0.00 7.50
Accounts Payable
35 30 30 32 41 40 42
Accrued Expenses
77 57 67 70 64 82 90
Dividends Payable
8.77 8.73 9.04 9.04 9.09 9.41 9.42
Other Current Liabilities
84 88 88 92 85 85 100
Total Noncurrent Liabilities
204 202 197 190 187 175 328
Long-Term Debt
- - - - - - 140
Asset Retirement Reserve & Litigation Obligation
73 74 75 77 77 78 79
Noncurrent Deferred & Payable Income Tax Liabilities
9.75 12 12 9.85 20 23 31
Other Noncurrent Operating Liabilities
119 117 109 103 90 73 78
Total Equity & Noncontrolling Interests
881 880 886 887 927 948 987
Total Preferred & Common Equity
877 877 884 885 925 946 983
Total Common Equity
877 877 884 885 925 946 983
Common Stock
229 225 226 227 227 230 231
Retained Earnings
659 660 667 668 705 722 756
Accumulated Other Comprehensive Income / (Loss)
-10 -7.85 -9.05 -10 -7.04 -5.91 -2.85
Noncontrolling Interest
4.02 2.80 2.44 2.17 1.77 2.03 3.33

Annual Metrics and Ratios for National HealthCare

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Growth Metrics
- - - - - - - - - - -
Revenue Growth
10.49% 4.01% 1.87% 4.37% 1.71% 1.64% 3.20% 4.48% 1.06% 5.14% 14.53%
EBITDA Growth
-8.53% 2.35% -2.58% -1.70% -0.36% 10.00% -9.15% -6.28% -23.63% 38.67% 27.29%
EBIT Growth
-16.62% 0.10% -5.94% -7.05% 0.45% 14.90% -13.20% -8.01% -37.35% 71.47% 42.90%
NOPAT Growth
-6.53% -1.81% -8.81% 5.95% 8.76% -13.84% 1.84% 22.39% -50.43% 79.65% 52.68%
Net Income Growth
-17.40% -0.42% -4.90% 10.18% 5.42% 15.80% -38.23% 231.24% -85.64% 226.82% 56.36%
EPS Growth
-18.86% 1.91% 3.75% 11.14% 4.88% 14.73% -38.74% 230.51% -83.87% 199.31% 50.46%
Operating Cash Flow Growth
-19.94% 1.73% 9.03% 3.94% 4.20% 1.69% 103.05% -69.30% -85.99% 1,172.20% -3.52%
Free Cash Flow Firm Growth
-139.27% 128.21% 417.78% 147.57% 8.01% -19.86% 272.85% -187.90% 68.63% 283.60% -283.80%
Invested Capital Growth
17.30% 10.03% 4.47% -1.81% -1.92% -0.94% -28.19% 61.64% 13.74% -6.71% 40.82%
Revenue Q/Q Growth
2.30% 0.84% 0.11% 1.10% 0.35% 0.50% 29.08% -15.83% -1.71% 3.29% 5.52%
EBITDA Q/Q Growth
0.65% 1.08% -1.97% -0.83% 3.08% 1.09% -18.92% 20.91% -6.80% 34.99% -5.48%
EBIT Q/Q Growth
-1.04% 1.03% -3.50% -2.42% 5.37% 1.41% -26.42% 38.92% -12.99% 63.75% -7.23%
NOPAT Q/Q Growth
-1.67% -0.67% -2.69% 15.36% -8.52% -1.06% -11.03% -4.54% -1.69% 26.54% 8.97%
Net Income Q/Q Growth
-4.55% 1.78% -2.15% 15.41% -5.11% -6.14% 48.58% -7.59% -34.28% 52.20% -17.69%
EPS Q/Q Growth
-3.38% 3.56% -2.92% 15.67% -5.15% -6.33% 50.28% -7.89% -29.95% 49.14% -18.27%
Operating Cash Flow Q/Q Growth
16.84% -4.54% 7.16% -2.71% -2.09% 4.00% -2.80% -5.79% -29.11% 14.16% -10.76%
Free Cash Flow Firm Q/Q Growth
43.74% -78.49% 83.08% 9.72% 12.31% 0.53% -5.13% -6.46% 7.11% 36.83% -27.62%
Invested Capital Q/Q Growth
0.72% 4.03% 1.46% 1.75% -0.58% -0.73% 0.19% 1.39% 0.54% -1.81% 3.92%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
41.46% 41.24% 40.66% 40.65% 40.56% 40.50% 39.61% 38.00% 36.80% 37.60% 37.97%
EBITDA Margin
13.72% 13.50% 12.91% 12.16% 11.91% 12.89% 11.35% 10.18% 7.69% 10.15% 11.28%
Operating Margin
7.80% 7.40% 6.56% 5.61% 5.72% 4.92% 4.68% 4.74% 2.94% 5.01% 6.56%
EBIT Margin
9.77% 9.41% 8.68% 7.73% 7.64% 8.64% 7.26% 6.39% 3.96% 6.46% 8.07%
Profit (Net Income) Margin
6.12% 5.86% 5.47% 5.78% 5.99% 6.82% 4.08% 12.95% 1.84% 5.72% 7.81%
Tax Burden Percent
62.64% 62.32% 63.01% 74.69% 78.39% 77.23% 80.10% 92.70% 73.36% 73.57% 74.84%
Interest Burden Percent
100.00% 100.00% 100.00% 100.00% 100.00% 102.30% 70.20% 218.40% 63.27% 120.25% 129.36%
Effective Tax Rate
37.36% 37.68% 36.99% 25.31% 21.61% 22.77% 19.90% 7.30% 26.64% 26.43% 25.16%
Return on Invested Capital (ROIC)
12.12% 10.50% 8.94% 9.35% 10.36% 9.06% 10.79% 12.08% 4.53% 7.92% 10.40%
ROIC Less NNEP Spread (ROIC-NNEP)
9.13% 6.52% 3.39% 3.35% 5.36% 0.17% 10.00% -7.79% 5.44% 1.51% -1.10%
Return on Net Nonoperating Assets (RNNOA)
-4.62% -2.71% -1.17% -1.24% -2.20% -0.08% -5.47% 4.22% -2.30% -0.61% 0.38%
Return on Equity (ROE)
7.50% 7.79% 7.77% 8.11% 8.16% 8.98% 5.32% 16.30% 2.24% 7.30% 10.78%
Cash Return on Invested Capital (CROIC)
-3.80% 0.95% 4.57% 11.17% 12.30% 10.00% 43.60% -35.04% -8.32% 14.86% -23.50%
Operating Return on Assets (OROA)
8.28% 8.05% 7.52% 6.83% 6.88% 7.27% 5.64% 4.97% 3.21% 5.71% 7.44%
Return on Assets (ROA)
5.19% 5.01% 4.74% 5.10% 5.39% 5.74% 3.17% 10.06% 1.49% 5.05% 7.20%
Return on Common Equity (ROCE)
5.71% 6.81% 7.77% 8.11% 8.15% 8.97% 5.31% 16.22% 2.23% 7.28% 10.76%
Return on Equity Simple (ROE_SIMPLE)
7.27% 8.42% 7.55% 7.92% 8.01% 8.73% 5.28% 15.40% 2.29% 7.18% 10.42%
Net Operating Profit after Tax (NOPAT)
43 42 38 40 44 38 39 47 23 42 64
NOPAT Margin
4.89% 4.61% 4.13% 4.19% 4.48% 3.80% 3.75% 4.39% 2.16% 3.68% 4.91%
Net Nonoperating Expense Percent (NNEP)
2.99% 3.98% 5.54% 6.00% 5.00% 8.89% 0.79% 19.87% -0.91% 6.41% 11.50%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - - 2.65% 4.61% 5.73%
Cost of Revenue to Revenue
58.54% 58.76% 59.34% 59.35% 59.44% 59.50% 60.40% 62.00% 63.20% 62.40% 62.03%
SG&A Expenses to Revenue
24.91% 25.05% 24.99% 25.92% 25.91% 26.94% 26.76% 24.83% 26.65% 25.25% 24.58%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
33.66% 33.84% 34.11% 35.04% 34.84% 35.58% 34.92% 33.26% 33.86% 32.59% 31.41%
Earnings before Interest and Taxes (EBIT)
85 85 80 75 75 86 75 69 43 74 105
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
120 122 119 117 117 128 117 109 84 116 147
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
0.00 1.13 1.37 1.08 1.38 1.47 1.15 1.07 0.99 1.52 1.69
Price to Tangible Book Value (P/TBV)
0.00 1.17 1.41 1.11 1.42 1.52 1.18 1.33 1.23 1.89 2.10
Price to Revenue (P/Rev)
0.00 0.79 0.99 0.79 1.03 1.15 0.89 0.90 0.79 1.21 1.27
Price to Earnings (P/E)
0.00 15.44 18.14 13.54 17.13 16.83 21.81 6.97 38.40 20.73 16.29
Dividend Yield
2.81% 3.21% 2.89% 3.77% 2.99% 2.75% 3.50% 3.37% 4.02% 2.59% 2.25%
Earnings Yield
0.00% 6.48% 5.51% 7.39% 5.84% 5.94% 4.58% 14.34% 2.60% 4.82% 6.14%
Enterprise Value to Invested Capital (EV/IC)
0.00 1.19 1.56 1.12 1.65 1.87 1.37 1.12 0.96 1.91 1.93
Enterprise Value to Revenue (EV/Rev)
0.00 0.55 0.73 0.50 0.70 0.78 0.40 0.50 0.49 0.86 1.07
Enterprise Value to EBITDA (EV/EBITDA)
0.00 4.07 5.69 4.10 5.92 6.07 3.52 4.94 6.34 8.46 9.46
Enterprise Value to EBIT (EV/EBIT)
0.00 5.84 8.46 6.45 9.23 9.06 5.50 7.86 12.30 13.29 13.22
Enterprise Value to NOPAT (EV/NOPAT)
0.00 11.91 17.79 11.90 15.72 20.58 10.65 11.43 22.62 23.32 21.72
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 5.98 7.47 5.09 7.02 7.79 2.02 8.65 60.55 8.82 12.99
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 132.21 34.79 9.96 13.25 18.64 2.64 0.00 0.00 12.43 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.06 0.24 0.22 0.18 0.11 0.04 0.02 0.00 0.01 0.00 0.14
Long-Term Debt to Equity
0.06 0.24 0.22 0.17 0.10 0.02 0.01 0.00 0.00 0.00 0.13
Financial Leverage
-0.51 -0.42 -0.34 -0.37 -0.41 -0.45 -0.55 -0.54 -0.42 -0.41 -0.35
Leverage Ratio
1.45 1.55 1.64 1.59 1.51 1.56 1.68 1.62 1.50 1.45 1.50
Compound Leverage Factor
1.45 1.55 1.64 1.59 1.51 1.60 1.18 3.54 0.95 1.74 1.94
Debt to Total Capital
5.97% 19.57% 18.32% 15.27% 9.61% 3.60% 1.84% 0.00% 0.66% 0.09% 12.23%
Short-Term Debt to Total Capital
0.40% 0.42% 0.42% 0.45% 0.48% 1.75% 0.54% 0.00% 0.56% 0.09% 0.67%
Long-Term Debt to Total Capital
5.57% 19.15% 17.90% 14.82% 9.12% 1.85% 1.30% 0.00% 0.10% 0.00% 11.56%
Preferred Equity to Total Capital
21.84% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.08% 0.15% 0.06% 0.38% 0.60% 0.37% 0.19% 0.27%
Common Equity to Total Capital
72.19% 80.43% 81.68% 84.65% 90.25% 96.34% 97.78% 99.40% 98.97% 99.72% 87.50%
Debt to EBITDA
0.39 1.25 1.26 1.08 0.67 0.23 0.13 0.00 0.07 0.01 0.93
Net Debt to EBITDA
-2.99 -1.77 -2.00 -2.39 -2.74 -2.87 -4.33 0.00 -4.02 -3.50 -1.83
Long-Term Debt to EBITDA
0.36 1.23 1.23 1.05 0.63 0.12 0.09 0.00 0.01 0.00 0.88
Debt to NOPAT
1.09 3.67 3.94 3.14 1.78 0.77 0.39 0.00 0.25 0.02 2.13
Net Debt to NOPAT
-8.41 -5.19 -6.24 -6.94 -7.29 -9.75 -13.11 0.00 -14.35 -9.65 -4.20
Long-Term Debt to NOPAT
1.02 3.59 3.85 3.04 1.69 0.40 0.27 0.00 0.04 0.00 2.02
Altman Z-Score
0.00 2.81 3.07 2.99 3.74 3.09 2.64 2.91 3.13 4.04 3.77
Noncontrolling Interest Sharing Ratio
23.98% 12.49% 0.00% 0.05% 0.13% 0.11% 0.23% 0.50% 0.49% 0.28% 0.25%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.76 1.85 1.93 2.12 2.04 1.75 1.62 1.62 1.79 1.89 1.81
Quick Ratio
1.53 1.59 1.66 1.98 1.90 1.53 1.47 1.52 1.43 1.55 1.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-13 3.77 20 48 52 42 156 -137 -43 79 -145
Operating Cash Flow to CapEx
153.74% 142.69% 145.18% 292.04% 386.44% 379.18% 1,344.04% 158.36% 33.59% 398.61% 420.80%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.85 0.86 0.87 0.88 0.90 0.84 0.78 0.78 0.81 0.88 0.92
Accounts Receivable Turnover
10.99 11.13 11.09 11.39 10.65 10.47 11.26 11.56 11.07 10.95 10.72
Inventory Turnover
71.50 72.51 72.70 78.04 79.70 79.52 76.56 76.72 87.58 98.43 98.74
Fixed Asset Turnover
1.79 1.73 1.69 1.74 1.81 1.86 1.95 2.06 2.11 2.28 2.22
Accounts Payable Turnover
13.89 14.10 15.14 16.59 16.83 16.97 17.35 17.16 18.63 20.02 20.69
Days Sales Outstanding (DSO)
33.23 32.80 32.93 32.05 34.26 34.85 32.42 31.56 32.96 33.34 34.04
Days Inventory Outstanding (DIO)
5.11 5.03 5.02 4.68 4.58 4.59 4.77 4.76 4.17 3.71 3.70
Days Payable Outstanding (DPO)
26.28 25.90 24.11 22.01 21.68 21.51 21.04 21.28 19.59 18.23 17.65
Cash Conversion Cycle (CCC)
12.05 11.94 13.84 14.73 17.16 17.93 16.15 15.04 17.54 18.82 20.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
379 417 436 428 420 416 299 483 549 513 722
Invested Capital Turnover
2.48 2.28 2.16 2.23 2.31 2.38 2.88 2.75 2.10 2.15 2.12
Increase / (Decrease) in Invested Capital
56 38 19 -7.87 -8.20 -3.93 -117 184 66 -37 209
Enterprise Value (EV)
0.00 498 679 481 691 779 411 540 529 980 1,394
Market Capitalization
0.00 715 917 761 1,010 1,148 913 967 862 1,385 1,661
Book Value per Share
$40.80 $42.33 $44.20 $46.24 $48.14 $50.83 $51.77 $58.55 $56.98 $59.30 $63.48
Tangible Book Value per Share
$39.52 $41.15 $43.04 $45.08 $46.76 $49.46 $50.38 $47.18 $45.55 $47.86 $51.15
Total Capital
781 785 820 830 813 808 813 908 883 911 1,120
Total Debt
47 154 150 127 78 29 15 0.00 5.85 0.86 137
Total Long-Term Debt
44 150 147 123 74 15 11 0.00 0.86 0.00 130
Net Debt
-358 -217 -238 -281 -320 -369 -506 -432 -336 -406 -270
Capital Expenditures (CapEx)
53 58 63 32 25 26 15 39 26 28 26
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-87 -50 -47 -48 -44 -72 -174 -151 -75 -88 -73
Debt-free Net Working Capital (DFNWC)
142 132 143 178 168 160 180 163 161 193 197
Net Working Capital (NWC)
139 128 140 174 164 146 176 163 156 192 190
Net Nonoperating Expense (NNE)
-11 -11 -12 -15 -15 -30 -3.42 -92 3.42 -23 -38
Net Nonoperating Obligations (NNO)
-355 -214 -234 -275 -314 -363 -499 -425 -328 -398 -261
Total Depreciation and Amortization (D&A)
34 37 39 43 42 42 42 41 40 42 42
Debt-free, Cash-free Net Working Capital to Revenue
-9.99% -5.50% -5.07% -4.95% -4.50% -7.21% -16.97% -14.03% -6.93% -7.74% -5.61%
Debt-free Net Working Capital to Revenue
16.30% 14.51% 15.53% 18.46% 17.14% 16.10% 17.50% 15.21% 14.83% 16.87% 15.08%
Net Working Capital to Revenue
15.94% 14.15% 15.15% 18.08% 16.74% 14.68% 17.07% 15.21% 14.37% 16.80% 14.50%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$3.24 $3.34 $3.34 $3.70 $3.87 $4.47 $2.74 $9.03 $1.46 $4.36 $6.62
Adjusted Weighted Average Basic Shares Outstanding
13.82M 13.89M 15.13M 15.19M 15.22M 15.27M 15.31M 15.35M 15.41M 15.31M 15.39M
Adjusted Diluted Earnings per Share
$3.14 $3.20 $3.32 $3.69 $3.87 $4.44 $2.72 $8.99 $1.45 $4.34 $6.53
Adjusted Weighted Average Diluted Shares Outstanding
14.22M 14.49M 15.21M 15.22M 15.24M 15.36M 15.37M 15.42M 15.45M 15.38M 15.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
14.11M 15.01M 15.18M 15.22M 15.26M 15.33M 15.37M 15.45M 15.36M 15.35M 15.45M
Normalized Net Operating Profit after Tax (NOPAT)
43 42 38 40 44 38 39 55 23 42 64
Normalized NOPAT Margin
4.89% 4.61% 4.13% 4.19% 4.48% 3.80% 3.75% 5.10% 2.16% 3.68% 4.91%
Pre Tax Income Margin
9.77% 9.41% 8.68% 7.73% 7.64% 8.83% 5.10% 13.97% 2.51% 7.77% 10.43%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
51.29% 56.59% 51.04% 50.71% 50.81% 46.60% 70.10% 23.72% 171.97% 54.47% 35.12%
Augmented Payout Ratio
64.40% 56.59% 67.26% 50.71% 52.29% 47.88% 70.22% 24.32% 221.54% 58.27% 48.34%

Quarterly Metrics and Ratios for National HealthCare

This table displays calculated financial ratios and metrics derived from National HealthCare's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Growth Metrics
- - - - - - - - - -
Revenue Growth
-2.13% -6.66% -3.38% 4.14% 6.51% 13.74% 10.24% 6.40% 17.93% 22.74%
EBITDA Growth
-35.35% -21.53% -10.27% 62.57% 59.75% 63.98% 30.83% 32.63% 31.67% 17.56%
EBIT Growth
-57.87% -35.37% -17.69% 149.90% 151.46% 110.09% 48.69% 55.47% 47.59% 27.27%
NOPAT Growth
-68.05% -2.13% -32.35% 257.00% 229.18% 125.51% 59.85% 67.35% 64.79% 72.30%
Net Income Growth
12.38% -65.15% -26.48% 636.56% 425.75% 401.70% 132.62% 70.30% 321.90% -78.44%
EPS Growth
27.27% -60.19% -23.23% 404.76% 525.00% 348.78% 122.37% 63.21% 301.47% -79.35%
Operating Cash Flow Growth
-129.29% -23.12% 150.47% 49.84% 1,734.04% 115.63% -30.39% 28.84% 5.89% -50.30%
Free Cash Flow Firm Growth
60.28% 66.40% 101.98% 108.03% 150.35% 187.64% 695.63% 751.14% -564.09% -450.07%
Invested Capital Growth
14.71% 13.74% 0.45% 0.68% -4.47% -6.71% -4.79% -7.02% 33.05% 40.82%
Revenue Q/Q Growth
-0.19% -2.32% 1.89% 4.83% 2.09% 4.31% -1.24% 1.17% 13.15% 8.57%
EBITDA Q/Q Growth
-0.06% 30.22% 280.27% 13.83% -1.80% 33.66% -37.91% 15.40% -2.51% 19.34%
EBIT Q/Q Growth
-3.72% 72.42% 452.56% 23.29% -3.12% 44.05% -46.19% 28.91% -8.03% 24.21%
NOPAT Q/Q Growth
2.26% 138.38% 5.61% 38.67% -5.71% 63.31% -25.14% 45.18% -7.16% 70.76%
Net Income Q/Q Growth
-243.78% 279.40% 102.46% 41.05% -36.41% 176.31% -6.13% 3.26% 57.53% -85.88%
EPS Q/Q Growth
-176.19% 356.25% 85.37% 39.47% -35.85% 170.59% -8.15% 2.37% 57.80% -86.08%
Operating Cash Flow Q/Q Growth
-107.53% 703.64% 16.11% 183.76% -17.84% -20.34% -62.52% 425.20% -32.48% -62.61%
Free Cash Flow Firm Q/Q Growth
15.24% 11.37% 107.95% 34.51% 431.30% 54.27% -27.84% 43.90% -389.70% -16.37%
Invested Capital Q/Q Growth
2.96% 0.54% -0.45% -2.31% -2.31% -1.81% 1.60% -4.60% 39.80% 3.92%
Profitability Metrics
- - - - - - - - - -
Gross Margin
36.05% 36.75% 37.74% 37.97% 36.68% 38.00% 38.37% 40.11% 37.27% 36.56%
EBITDA Margin
6.30% 8.40% 9.05% 9.82% 9.45% 12.11% 10.73% 12.24% 10.55% 11.60%
Operating Margin
1.51% 3.42% 3.71% 4.95% 4.52% 6.69% 5.26% 7.49% 6.19% 7.19%
EBIT Margin
2.51% 4.44% 5.32% 6.25% 5.94% 8.20% 7.17% 9.14% 7.43% 8.50%
Profit (Net Income) Margin
-1.15% 2.11% 4.19% 5.63% 3.51% 9.29% 8.83% 9.02% 12.55% 1.63%
Tax Burden Percent
73.16% 75.19% 71.78% 71.30% 72.14% 76.27% 73.51% 74.06% 73.57% 99.54%
Interest Burden Percent
-62.37% 63.14% 109.67% 126.31% 81.94% 148.66% 167.56% 133.21% 229.66% 19.30%
Effective Tax Rate
0.00% 24.81% 28.22% 28.70% 27.86% 23.73% 26.49% 25.94% 26.43% 0.46%
Return on Invested Capital (ROIC)
2.28% 5.41% 5.26% 7.20% 6.74% 10.96% 8.47% 12.77% 9.27% 15.17%
ROIC Less NNEP Spread (ROIC-NNEP)
3.84% 5.74% 4.09% 5.56% 6.53% 7.49% 4.47% 10.18% 0.99% 21.36%
Return on Net Nonoperating Assets (RNNOA)
-1.64% -2.42% -1.60% -2.25% -2.59% -3.04% -1.83% -4.46% -0.35% -7.44%
Return on Equity (ROE)
0.64% 2.99% 3.66% 4.95% 4.15% 7.92% 6.64% 8.32% 8.92% 7.73%
Cash Return on Invested Capital (CROIC)
-9.05% -8.32% 3.15% 4.34% 10.79% 14.86% 13.58% 17.56% -18.68% -23.50%
Operating Return on Assets (OROA)
2.05% 3.60% 4.37% 5.17% 5.09% 7.24% 6.49% 8.28% 6.47% 7.84%
Return on Assets (ROA)
-0.93% 1.71% 3.44% 4.66% 3.01% 8.20% 7.99% 8.17% 10.93% 1.51%
Return on Common Equity (ROCE)
0.63% 2.98% 3.64% 4.93% 4.14% 7.90% 6.62% 8.30% 8.90% 7.71%
Return on Equity Simple (ROE_SIMPLE)
3.46% 0.00% 1.81% 3.36% 4.85% 0.00% 8.68% 9.67% 12.61% 0.00%
Net Operating Profit after Tax (NOPAT)
2.85 6.80 7.19 9.97 9.40 15 11 17 15 26
NOPAT Margin
1.05% 2.57% 2.67% 3.53% 3.26% 5.10% 3.87% 5.55% 4.55% 7.16%
Net Nonoperating Expense Percent (NNEP)
-1.57% -0.33% 1.17% 1.64% 0.21% 3.48% 4.00% 2.60% 8.28% -6.19%
Return On Investment Capital (ROIC_SIMPLE)
- 0.77% - - - 1.68% - - - 2.36%
Cost of Revenue to Revenue
63.95% 63.25% 62.26% 62.03% 63.32% 62.00% 61.63% 59.89% 62.73% 63.44%
SG&A Expenses to Revenue
26.91% 26.87% 26.52% 25.92% 25.13% 23.58% 26.05% 25.99% 24.25% 22.55%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
34.55% 33.32% 34.03% 33.02% 32.17% 31.32% 33.11% 32.62% 31.09% 29.37%
Earnings before Interest and Taxes (EBIT)
6.81 12 14 18 17 25 21 27 25 31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
17 22 24 28 27 36 32 37 36 43
Valuation Ratios
- - - - - - - - - -
Price to Book Value (P/BV)
1.06 0.99 0.98 1.04 1.08 1.52 1.56 1.77 1.97 1.69
Price to Tangible Book Value (P/TBV)
1.32 1.23 1.22 1.30 1.35 1.89 1.92 2.17 2.44 2.10
Price to Revenue (P/Rev)
0.84 0.79 0.80 0.85 0.87 1.21 1.23 1.41 1.57 1.27
Price to Earnings (P/E)
29.08 38.40 45.58 28.86 21.40 20.73 17.72 18.17 15.61 16.29
Dividend Yield
3.74% 4.02% 4.07% 3.82% 3.71% 2.59% 2.51% 2.20% 1.91% 2.25%
Earnings Yield
3.44% 2.60% 2.19% 3.47% 4.67% 4.82% 5.64% 5.50% 6.41% 6.14%
Enterprise Value to Invested Capital (EV/IC)
1.08 0.96 0.95 1.06 1.12 1.91 1.97 2.44 2.37 1.93
Enterprise Value to Revenue (EV/Rev)
0.53 0.49 0.48 0.52 0.53 0.86 0.88 1.02 1.33 1.07
Enterprise Value to EBITDA (EV/EBITDA)
6.58 6.34 8.03 7.46 6.84 8.46 7.43 8.23 10.53 9.46
Enterprise Value to EBIT (EV/EBIT)
11.92 12.30 21.59 16.23 13.02 13.29 10.74 11.49 14.45 13.22
Enterprise Value to NOPAT (EV/NOPAT)
24.76 22.62 26.52 21.10 17.66 23.32 22.20 22.87 27.89 21.72
Enterprise Value to Operating Cash Flow (EV/OCF)
47.79 60.55 10.42 8.93 6.02 8.82 9.61 10.24 13.66 12.99
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 30.29 24.38 10.17 12.43 14.18 13.39 0.00 0.00
Leverage & Solvency
- - - - - - - - - -
Debt to Equity
0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.15 0.14
Long-Term Debt to Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 0.13
Financial Leverage
-0.43 -0.42 -0.39 -0.40 -0.40 -0.41 -0.41 -0.44 -0.35 -0.35
Leverage Ratio
1.52 1.50 1.46 1.47 1.46 1.45 1.43 1.43 1.52 1.50
Compound Leverage Factor
-0.95 0.95 1.61 1.86 1.19 2.15 2.40 1.90 3.49 0.29
Debt to Total Capital
0.79% 0.66% 0.00% 0.38% 0.24% 0.09% 0.00% 0.00% 12.97% 12.23%
Short-Term Debt to Total Capital
0.55% 0.56% 0.00% 0.38% 0.24% 0.09% 0.00% 0.00% 0.66% 0.67%
Long-Term Debt to Total Capital
0.24% 0.10% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.30% 11.56%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.45% 0.37% 0.32% 0.27% 0.24% 0.19% 0.19% 0.21% 0.29% 0.27%
Common Equity to Total Capital
98.75% 98.97% 99.68% 99.35% 99.52% 99.72% 99.81% 99.79% 86.74% 87.50%
Debt to EBITDA
0.08 0.07 0.00 0.04 0.02 0.01 0.00 0.00 0.94 0.93
Net Debt to EBITDA
-3.81 -4.02 0.00 -4.76 -4.35 -3.50 0.00 0.00 -1.93 -1.83
Long-Term Debt to EBITDA
0.02 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.89 0.88
Debt to NOPAT
0.30 0.25 0.00 0.13 0.06 0.02 0.00 0.00 2.50 2.13
Net Debt to NOPAT
-14.36 -14.35 0.00 -13.47 -11.24 -9.65 0.00 0.00 -5.10 -4.20
Long-Term Debt to NOPAT
0.09 0.04 0.00 0.00 0.00 0.00 0.00 0.00 2.37 2.02
Altman Z-Score
3.05 3.05 3.10 3.19 3.26 3.92 4.08 4.47 3.70 3.61
Noncontrolling Interest Sharing Ratio
0.57% 0.49% 0.48% 0.40% 0.35% 0.28% 0.25% 0.24% 0.29% 0.25%
Liquidity Ratios
- - - - - - - - - -
Current Ratio
1.64 1.79 1.84 1.86 1.87 1.89 2.02 2.06 1.80 1.81
Quick Ratio
1.31 1.43 1.59 1.49 1.53 1.55 1.66 1.75 1.53 1.65
Cash Flow Metrics
- - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-67 -60 4.73 6.37 34 52 38 54 -157 -183
Operating Cash Flow to CapEx
-26.26% 211.71% 208.69% 639.47% 496.16% 299.19% 161.98% 646.76% 604.79% 156.80%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - -
Asset Turnover
0.81 0.81 0.82 0.83 0.86 0.88 0.90 0.91 0.87 0.92
Accounts Receivable Turnover
11.16 11.07 10.51 10.79 10.96 10.95 10.22 11.27 10.71 10.72
Inventory Turnover
87.74 87.58 87.99 95.23 94.49 98.43 106.16 107.50 100.33 98.74
Fixed Asset Turnover
2.14 2.11 2.10 2.14 2.19 2.28 2.36 2.40 2.09 2.22
Accounts Payable Turnover
16.53 18.63 18.78 18.39 20.69 20.02 20.70 20.87 20.74 20.69
Days Sales Outstanding (DSO)
32.72 32.96 34.74 33.84 33.29 33.34 35.71 32.38 34.08 34.04
Days Inventory Outstanding (DIO)
4.16 4.17 4.15 3.83 3.86 3.71 3.44 3.40 3.64 3.70
Days Payable Outstanding (DPO)
22.08 19.59 19.44 19.84 17.64 18.23 17.63 17.49 17.60 17.65
Cash Conversion Cycle (CCC)
14.80 17.54 19.45 17.83 19.51 18.82 21.52 18.29 20.12 20.09
Capital & Investment Metrics
- - - - - - - - - -
Invested Capital
546 549 547 534 522 513 521 497 695 722
Invested Capital Turnover
2.16 2.10 1.97 2.04 2.07 2.15 2.19 2.30 2.04 2.12
Increase / (Decrease) in Invested Capital
70 66 2.45 3.60 -24 -37 -26 -38 173 209
Enterprise Value (EV)
589 529 521 564 587 980 1,028 1,212 1,643 1,394
Market Capitalization
927 862 859 921 958 1,385 1,440 1,669 1,940 1,661
Book Value per Share
$56.65 $56.98 $57.12 $57.70 $57.78 $59.30 $60.24 $61.42 $63.76 $63.48
Tangible Book Value per Share
$45.32 $45.55 $45.70 $46.25 $46.33 $47.86 $48.82 $50.03 $51.48 $51.15
Total Capital
888 883 880 890 889 911 927 948 1,134 1,120
Total Debt
7.05 5.85 0.00 3.39 2.13 0.86 0.00 0.00 147 137
Total Long-Term Debt
2.13 0.86 0.00 0.00 0.00 0.00 0.00 0.00 140 130
Net Debt
-342 -336 -341 -360 -373 -406 -414 -459 -300 -270
Capital Expenditures (CapEx)
7.53 5.64 6.64 6.15 6.51 8.60 5.96 7.83 5.66 8.16
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-89 -75 -65 -76 -85 -88 -67 -91 -98 -73
Debt-free Net Working Capital (DFNWC)
139 161 155 174 180 193 211 231 205 197
Net Working Capital (NWC)
134 156 155 171 178 192 211 231 198 190
Net Nonoperating Expense (NNE)
5.96 1.23 -4.10 -5.95 -0.72 -13 -15 -10 -27 20
Net Nonoperating Obligations (NNO)
-335 -328 -333 -352 -365 -398 -406 -451 -292 -261
Total Depreciation and Amortization (D&A)
10 10 10 10 10 12 11 9.34 11 11
Debt-free, Cash-free Net Working Capital to Revenue
-8.02% -6.93% -6.03% -6.95% -7.69% -7.74% -5.71% -7.70% -7.94% -5.61%
Debt-free Net Working Capital to Revenue
12.61% 14.83% 14.37% 16.03% 16.29% 16.87% 18.06% 19.45% 16.57% 15.08%
Net Working Capital to Revenue
12.16% 14.37% 14.37% 15.72% 16.10% 16.80% 18.06% 19.45% 15.96% 14.50%
Earnings Adjustments
- - - - - - - - - -
Adjusted Basic Earnings per Share
($0.16) $0.42 $0.76 $1.06 $0.68 $1.86 $1.71 $1.74 $2.78 $0.39
Adjusted Weighted Average Basic Shares Outstanding
15.45M 15.41M 15.34M 15.30M 15.30M 15.31M 15.35M 15.39M 15.41M 15.39M
Adjusted Diluted Earnings per Share
($0.16) $0.41 $0.76 $1.06 $0.68 $1.84 $1.69 $1.73 $2.73 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
15.45M 15.45M 15.36M 15.32M 15.32M 15.38M 15.51M 15.56M 15.67M 15.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
15.34M 15.36M 15.32M 15.32M 15.32M 15.35M 15.40M 15.42M 15.44M 15.45M
Normalized Net Operating Profit after Tax (NOPAT)
2.85 6.80 7.19 9.97 9.40 15 11 17 15 26
Normalized NOPAT Margin
1.05% 2.57% 2.67% 3.53% 3.26% 5.10% 3.87% 5.55% 4.55% 7.16%
Pre Tax Income Margin
-1.57% 2.80% 5.83% 7.90% 4.86% 12.18% 12.02% 12.17% 17.06% 1.64%
Debt Service Ratios
- - - - - - - - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - -
Dividend Payout Ratio
113.70% 171.97% 219.06% 118.25% 82.28% 54.47% 44.69% 39.61% 28.38% 35.12%
Augmented Payout Ratio
138.26% 221.54% 295.97% 159.50% 95.05% 58.27% 57.02% 52.07% 39.27% 48.34%

Frequently Asked Questions About National HealthCare's Financials

When does National HealthCare's fiscal year end?

According to the most recent income statement we have on file, National HealthCare's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has National HealthCare's net income changed over the last 10 years?

National HealthCare's net income appears to be on an upward trend, with a most recent value of $102.09 million in 2024, rising from $53.37 million in 2014. The previous period was $65.29 million in 2023.

What is National HealthCare's operating income?
National HealthCare's total operating income in 2024 was $85.76 million, based on the following breakdown:
  • Total Gross Profit: $496.45 million
  • Total Operating Expenses: $410.69 million
How has National HealthCare revenue changed over the last 10 years?

Over the last 10 years, National HealthCare's total revenue changed from $871.68 million in 2014 to $1.31 billion in 2024, a change of 50.0%.

How much debt does National HealthCare have?

National HealthCare's total liabilities were at $541.27 million at the end of 2024, a 35.2% increase from 2023, and a 59.2% increase since 2014.

How much cash does National HealthCare have?

In the past 10 years, National HealthCare's cash and equivalents has ranged from $26.34 million in 2016 to $147.09 million in 2020, and is currently $76.12 million as of their latest financial filing in 2024.

How has National HealthCare's book value per share changed over the last 10 years?

Over the last 10 years, National HealthCare's book value per share changed from 40.80 in 2014 to 63.48 in 2024, a change of 55.6%.



This page (NYSEAMERICAN:NHC) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners